BILL · 2009–10 SESSION

SB 5512: Chemotherapy treatment costs

Requiring financial parity for oral and intravenous or injected chemotherapy treatment costs.

Summary

Beginning January 1, 2010, all health plans that include coverage for cancer chemotherapy treatment must cover orally administered anticancer medication not less favorably than intravenously administered or injected cancer medications, including copayments. The requirements are extended to individual plans, group plans, Basic Health plans, and Public Employees Benefits Board plans.

From the Senate Bill Report (Orig.) (SB 5512), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee

AN ACT Relating to chemotherapy treatment costs;

No recorded floor votes. This measure never reached a floor vote.

Bill numbers restart every two years, so the same number is a different bill in each session.

SB 5512 (2025–26) House-banked card rooms · Did not pass · died in committee
SB 5512 (2023–24) Higher ed. financial reports · Enacted · Chapter 98, Laws of 2023
SB 5512 (2021–22) State nickname · Did not pass · passed Senate, stalled in House
SB 5512 (2019–20) Teacher prep. skills assess. · Did not pass · stalled on the Senate floor
SB 5512 (2017–18) State hospitals/DOH · Did not pass · died in committee
SB 5512 (2015–16) Retro rating plan emps, grps · Did not pass · died in committee
SB 5512 (2013–14) School administrators · Did not pass · died in committee
SB 5512 (2011–12) Access to public records · Did not pass · died in committee